RNAi Developer Sirnaomics Targets Untapped Oncology Indications In China

 
• By Dexter Jie Yan
  
china clinical trial
Sirnaomics brings China sites into international studies of lead siRNA assets • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia